2020
DOI: 10.1055/a-1023-5221
|View full text |Cite
|
Sign up to set email alerts
|

Multiple endokrine Neoplasie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…MEN1 is characterized by the combined occurrence of parathyroid, pituitary and pancreatic neuroendocrine tumors, whereas MEN2 features medullary thyroid cancer in association with phaeochromocytoma and parathyroid tumors. Although both MEN1 and MEN2 are autosomal dominant disorders, they have contrasting molecular etiologies: MEN1 results from inactivating germline mutations of the MEN1 tumor suppressor gene on chromosome 11 (14), whereas MEN2 results from activating mutations in the RET proto-oncogene. Fully understanding if patients have hyperparathyroidism or MEN family history aids in the early diagnosis or treatment of APA.…”
Section: Figurementioning
confidence: 99%
“…MEN1 is characterized by the combined occurrence of parathyroid, pituitary and pancreatic neuroendocrine tumors, whereas MEN2 features medullary thyroid cancer in association with phaeochromocytoma and parathyroid tumors. Although both MEN1 and MEN2 are autosomal dominant disorders, they have contrasting molecular etiologies: MEN1 results from inactivating germline mutations of the MEN1 tumor suppressor gene on chromosome 11 (14), whereas MEN2 results from activating mutations in the RET proto-oncogene. Fully understanding if patients have hyperparathyroidism or MEN family history aids in the early diagnosis or treatment of APA.…”
Section: Figurementioning
confidence: 99%